BioSpace News Archive

Rady Children’s Hospital-San Diego, recognized by U.S. News & World Report as one of the nation’s top children’s hospitals in all 10 specialties surveyed, treats young orthopaedic patients quickly and efficiently with the CARESTREAM OnSight 3D Extremity Imaging System, designed to offer convenient high-quality image processing for a rapid diagnosis at the point of care.

Neogen Corporation (NASDAQ: NEOG) announced today that, in line with yesterday’s Federal Trade Commission (FTC) press release, it plans to acquire the U.S. (including territories) rights to Elanco’s StandGuard ® Pour-on for horn fly and lice control in beef cattle, and related assets. Closing remains subject to a final FTC consent de

Development funded under contract award from NIAID/NIH as part of the CIVICs program Currently no approved universal influenza vaccine CDC estimates 35.5 million people were infected with influenza in U.S. during 2018-2019 season Collaboration will combine Dynavax’s CpG 1018 with influenza antigens designed to protect against all strains of influenza NEW YORK and EMERYVILLE, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical c

BioSpace Inc., the leader in life sciences news and careers, announced today that they have released the BioSpace 2020 Salary Report.

Imprivata®, the digital identity company for healthcare, today announced its selection as the #1-ranked company for Client Satisfaction for Identity Governance solutions in the 2020 Black Book™ Survey of the top healthcare industry technology security solutions.

Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration NEW YORK, July 16, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it has entered into a research collab

Banner Health and Cerner Corporation®, a global health care technology company, have expanded their relationship to implement an end-to-end, comprehensive suite of revenue cycle management solutions, building on a multi-year, long-standing strategic alignment using health care technology to drive population health improvement.

Hackensack Meridian Health’s COVID Recovery Center aims to help recovered COVID-19 patients with potential virus side effects

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced biotech veteran Harry J. Leonhardt, Esq. has joined the company as General Counsel and Chief Com

Pharmaceutical innovator Galt Pharmaceuticals announced a new drug approval to offer a non-opioid, non-controlled, non-addictive alternative for healthcare providers to manage patients suffering from pain. On July 8, 2020 the U.S. Food and Drug Administration approved the company’s Supplemental Abbreviated New Drug Application for Orphengesic Forte, over two months ahead of the scheduled goal date. “This is a big win in the